NEW YORK--(BUSINESS WIRE)--Jan. 20, 2004--IntraLinks, Inc., trusted third party hub for the pharmaceutical industry, and Bio-Imaging Technologies, Inc. (Nasdaq: BITI - News), one of the world's largest independent and dedicated providers of medical image management services for clinical trials, today announced that they will form a strategic partnership. The companies will work together to develop standard methodologies around the exchange of forms, documents and other unstructured data to help speed the clinical trial process for their customers. IntraLinks and Bio-Imaging Technologies will work together to create templates and processes that will simplify information exchange for clients of both companies. Clients will also benefit from receiving reports and other documentation from Bio-Imaging Technologies in a secure and auditable format to help comply with regulatory guidelines. Bio-Imaging Technologies' clients will also be able to use IntraLinks to increase efficiency in non-trial related activities such as the completion of RFPs, contracts, letters, surveys and technical inquiries.
Mark Weinstein, president and CEO of Bio-Imaging, said, "We are pleased to offer our clients a more secure and efficient means to exchange critical trial documentation through IntraLinks. Our relationship will help our clients to connect to the community of trial participants that use the service to streamline their daily interactions."
Richard Jenkins, General Manager for Life Sciences at IntraLinks, said, "Our relationship with Bio-Imaging Technologies will enhance the network for the investigators, sponsors, contract research organizations and institutional review boards that use IntraLinks as their hub for trial communications. Through this partnership, we are offering our clients and users another way to increase their efficiency by bringing processes online."
About Bio-Imaging Technologies
Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab (Newtown, PA), European Core Lab (Leiden, The Netherlands) and US Business Offices (Massachusetts and California).
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
IntraLinks (www.intralinks.com), the leading provider of digital workspaces, connects business communities and accelerates the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication, and fostering rapid workflow. IntraLinks is easily accessible anywhere, anytime using a web browser.
Since April 1997, more than 100,000 participants representing over 3,000 companies worldwide have used IntraLinks digital workspaces to communicate and collaborate on more than 10,000 projects and transactions. IntraLinks has been rapidly adopted by the financial services and pharmaceutical markets. Over 100 global companies are IntraLinks clients, including AstraZeneca Pharmaceuticals LP, Bank of America, Bank One, Bear Stearns, Deutsche Bank, Dresdner Kleinwort Wasserstein, Ernst & Young, FDIC, Houlihan Lokey Howard & Zukin; International Finance Corporation (World Bank Group); JPMorgan Chase; TD Securities, Thomas Weisel Partners, Wachovia Securities and WestLB. Founded in June 1996, IntraLinks is a privately held company headquartered in New York with offices in Boston and London.
(IntraLinks Contact) Walek & Associates David Rosen, 212-889-4113 firstname.lastname@example.org or (Bio-Imaging Contacts) Mark L. Weinstein or Ted Kaminer 267/757-3000 or Porter, LeVay & Rose, Inc. Linda Decker or Jeff Myhre 212/564-4700